AG˹ٷ

STOCK TITAN

[Form 4] WESTLAKE CHEMICAL PARTNERS LP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Director G. Steven Finley filed a Form 4 for Westlake Chemical Partners LP (WLKP) covering two transactions on 8-6-25 and 8-7-25.

  • 8 Aug 2025 grant: Finley received 5,005 phantom units (economic equivalent of common units). These vest/exercisable 8-6-26 and expire 9-6-26; cost basis reported as $0.
  • 7 Aug 2025 conversion: Finley exercised 4,882 phantom units (Code M), acquiring the same number of WLKP common units at no cash cost. Direct common-unit holdings rose to 31,930 units from approximately 27,048, an ~18% increase.

No open-market purchases or sales were reported, and derivative holdings after the reported transactions stand at the newly granted 5,005 phantom units. The filing signals continued equity alignment by a board member but does not involve cash transactions or changes to public float.

Il direttore G. Steven Finley ha presentato un Modulo 4 per Westlake Chemical Partners LP (WLKP) relativo a due operazioni effettuate il 6 e il 7 agosto 2025.

  • Concessione del 6 agosto 2025: Finley ha ricevuto 5.005 unità fantasma (equivalenti economici alle unità ordinarie). Queste maturano/esercitabili il 6 agosto 2026 e scadono il 6 settembre 2026; il valore di costo dichiarato è $0.
  • Conversione del 7 agosto 2025: Finley ha esercitato 4.882 unità fantasma (Codice M), acquisendo lo stesso numero di unità ordinarie WLKP senza alcun esborso in denaro. La detenzione diretta di unità ordinarie è aumentata a 31.930 unità da circa 27.048, con un incremento di circa il 18%.

Non sono stati segnalati acquisti o vendite sul mercato aperto, e le partecipazioni derivati dopo le transazioni riportate ammontano alle 5.005 unità fantasma appena concesse. La comunicazione indica un continuo allineamento azionario da parte di un membro del consiglio, senza coinvolgimento di transazioni in denaro o variazioni del flottante pubblico.

El director G. Steven Finley presentó un Formulario 4 para Westlake Chemical Partners LP (WLKP) que cubre dos transacciones realizadas el 6 y 7 de agosto de 2025.

  • Concesión del 6 de agosto de 2025: Finley recibió 5,005 unidades fantasma (equivalentes económicos a unidades comunes). Estas se consolidan/pueden ejercerse el 6 de agosto de 2026 y vencen el 6 de septiembre de 2026; el costo base declarado es $0.
  • Conversión del 7 de agosto de 2025: Finley ejerció 4,882 unidades fantasma (Código M), adquiriendo el mismo número de unidades comunes de WLKP sin costo en efectivo. Las tenencias directas de unidades comunes aumentaron a 31,930 unidades desde aproximadamente 27,048, un incremento de alrededor del 18%.

No se reportaron compras o ventas en el mercado abierto, y las participaciones derivadas después de las transacciones reportadas son las 5,005 unidades fantasma recién otorgadas. La presentación señala una continua alineación accionaria por parte de un miembro del consejo, pero no implica transacciones en efectivo ni cambios en el flotante público.

이사 G. Steven 󾱲Ա� Westlake Chemical Partners LP (WLKP)� 위해 2025� 8� 6일과 8� 7일에 발생� � 건의 거래� 대� Form 4� 제출했습니다.

  • 2025� 8� 6� 부�: 󾱲Ա� 5,005개의 팬텀 유닛(보통주와 경제� 동등 단위)� 받았습니�. � 유닛들은 2026� 8� 6일에 베스�/행사 가능하�, 2026� 9� 6일에 만료됩니�; 신고� 원가� $0입니�.
  • 2025� 8� 7� 전환: 󾱲Ա� 4,882개의 팬텀 유닛(Code M)� 행사하여 동일� 수의 WLKP 보통주를 현금 지� 없이 취득했습니다. 직접 보유 보통� 수는 � 27,048에서 31,930�� � 18% 증가했습니다.

공개 시장에서� 매매� 보고되지 않았으며, 보고� 거래 � 파생 보유� 새로 부여된 5,005개의 팬텀 유닛으로 유지됩니�. 이번 제출은 이사� 구성원의 지속적� 주식 정렬� 나타내지� 현금 거래� 공개 유통 주식 변동과� 관련이 없습니다.

Le directeur G. Steven Finley a déposé un formulaire 4 pour Westlake Chemical Partners LP (WLKP) concernant deux transactions réalisées les 6 et 7 août 2025.

  • Attribution du 6 août 2025 : Finley a reçu 5 005 unités fantômes (équivalent économique des unités ordinaires). Celles-ci deviennent acquises/exerçables le 6 août 2026 et expirent le 6 septembre 2026 ; la valeur de base déclarée est de 0 $.
  • Conversion du 7 août 2025 : Finley a exercé 4 882 unités fantômes (Code M), acquérant le même nombre d’unités ordinaires WLKP sans coût en espèces. La détention directe d’unités ordinaires est passée à 31 930 unités contre environ 27 048, soit une augmentation d’environ 18 %.

Aucun achat ou vente sur le marché ouvert n’a été signalé, et les avoirs dérivés après les transactions déclarées s’élèvent aux 5 005 unités fantômes nouvellement attribuées. Le dépôt signale un alignement continu en actions par un membre du conseil, sans impliquer de transactions en espèces ni de modifications du flottant public.

Direktor G. Steven Finley reichte ein Formular 4 für Westlake Chemical Partners LP (WLKP) ein, das zwei Transaktionen am 6. und 7. August 2025 abdeckt.

  • Gewährung am 6. August 2025: Finley erhielt 5.005 Phantom-Einheiten (wirtschaftliches Äquivalent zu Stammaktien). Diese werden am 6. August 2026 fällig/ausübbar und verfallen am 6. September 2026; der gemeldete Anschaffungspreis beträgt 0 $.
  • Ausübung am 7. August 2025: Finley übte 4.882 Phantom-Einheiten (Code M) aus und erwarb die gleiche Anzahl von WLKP-Stammaktien ohne Barausgabe. Die direkten Stammaktienbestände stiegen von etwa 27.048 auf 31.930 Einheiten, eine Steigerung von ca. 18 %.

Es wurden keine Käufe oder Verkäufe am offenen Markt gemeldet, und die Derivatbestände nach den gemeldeten Transaktionen belaufen sich auf die neu gewährten 5.005 Phantom-Einheiten. Die Meldung signalisiert eine fortgesetzte Aktienausrichtung eines Vorstandsmitglieds, beinhaltet jedoch keine Bartransaktionen oder Änderungen des Streubesitzes.

Positive
  • Director’s direct ownership rose by 4,882 units (~18%), modestly strengthening insider alignment with common unitholders.
  • New 5,005-unit phantom award indicates ongoing long-term incentive structure without immediate cash outflow.
Negative
  • No open-market purchase; conversion at zero cost provides weaker bullish signal than buying on the market.
  • Immaterial impact on float and earnings, limiting relevance to near-term valuation.

Insights

TL;DR: Director converted 4,882 phantom units, increased direct stake 18%; received 5,005 new phantom units—neutral cash impact, mildly positive alignment.

The conversion simply turns deferred compensation into equity, adding 4,882 common units to Finley’s direct holdings. Although no cash was spent, the larger personal stake modestly tightens insider alignment with unitholders. The fresh 5,005-unit phantom award is routine board compensation and vests in one year. Overall impact on valuation, liquidity, and float is negligible; the signal is mildly constructive but not market-moving.

TL;DR: Routine board compensation; equity mix reinforces incentive structure, no red flags or significant dilution.

The grant and subsequent exercise are in line with standard LP governance practices, indicating WLKP continues to compensate directors with equity-linked awards to promote long-term orientation. No accelerated vesting, discounted pricing, or unusual structures are present. Because the units come from existing equity plans, dilution is de minimis. Governance quality appears intact; the disclosure is largely procedural.

Il direttore G. Steven Finley ha presentato un Modulo 4 per Westlake Chemical Partners LP (WLKP) relativo a due operazioni effettuate il 6 e il 7 agosto 2025.

  • Concessione del 6 agosto 2025: Finley ha ricevuto 5.005 unità fantasma (equivalenti economici alle unità ordinarie). Queste maturano/esercitabili il 6 agosto 2026 e scadono il 6 settembre 2026; il valore di costo dichiarato è $0.
  • Conversione del 7 agosto 2025: Finley ha esercitato 4.882 unità fantasma (Codice M), acquisendo lo stesso numero di unità ordinarie WLKP senza alcun esborso in denaro. La detenzione diretta di unità ordinarie è aumentata a 31.930 unità da circa 27.048, con un incremento di circa il 18%.

Non sono stati segnalati acquisti o vendite sul mercato aperto, e le partecipazioni derivati dopo le transazioni riportate ammontano alle 5.005 unità fantasma appena concesse. La comunicazione indica un continuo allineamento azionario da parte di un membro del consiglio, senza coinvolgimento di transazioni in denaro o variazioni del flottante pubblico.

El director G. Steven Finley presentó un Formulario 4 para Westlake Chemical Partners LP (WLKP) que cubre dos transacciones realizadas el 6 y 7 de agosto de 2025.

  • Concesión del 6 de agosto de 2025: Finley recibió 5,005 unidades fantasma (equivalentes económicos a unidades comunes). Estas se consolidan/pueden ejercerse el 6 de agosto de 2026 y vencen el 6 de septiembre de 2026; el costo base declarado es $0.
  • Conversión del 7 de agosto de 2025: Finley ejerció 4,882 unidades fantasma (Código M), adquiriendo el mismo número de unidades comunes de WLKP sin costo en efectivo. Las tenencias directas de unidades comunes aumentaron a 31,930 unidades desde aproximadamente 27,048, un incremento de alrededor del 18%.

No se reportaron compras o ventas en el mercado abierto, y las participaciones derivadas después de las transacciones reportadas son las 5,005 unidades fantasma recién otorgadas. La presentación señala una continua alineación accionaria por parte de un miembro del consejo, pero no implica transacciones en efectivo ni cambios en el flotante público.

이사 G. Steven 󾱲Ա� Westlake Chemical Partners LP (WLKP)� 위해 2025� 8� 6일과 8� 7일에 발생� � 건의 거래� 대� Form 4� 제출했습니다.

  • 2025� 8� 6� 부�: 󾱲Ա� 5,005개의 팬텀 유닛(보통주와 경제� 동등 단위)� 받았습니�. � 유닛들은 2026� 8� 6일에 베스�/행사 가능하�, 2026� 9� 6일에 만료됩니�; 신고� 원가� $0입니�.
  • 2025� 8� 7� 전환: 󾱲Ա� 4,882개의 팬텀 유닛(Code M)� 행사하여 동일� 수의 WLKP 보통주를 현금 지� 없이 취득했습니다. 직접 보유 보통� 수는 � 27,048에서 31,930�� � 18% 증가했습니다.

공개 시장에서� 매매� 보고되지 않았으며, 보고� 거래 � 파생 보유� 새로 부여된 5,005개의 팬텀 유닛으로 유지됩니�. 이번 제출은 이사� 구성원의 지속적� 주식 정렬� 나타내지� 현금 거래� 공개 유통 주식 변동과� 관련이 없습니다.

Le directeur G. Steven Finley a déposé un formulaire 4 pour Westlake Chemical Partners LP (WLKP) concernant deux transactions réalisées les 6 et 7 août 2025.

  • Attribution du 6 août 2025 : Finley a reçu 5 005 unités fantômes (équivalent économique des unités ordinaires). Celles-ci deviennent acquises/exerçables le 6 août 2026 et expirent le 6 septembre 2026 ; la valeur de base déclarée est de 0 $.
  • Conversion du 7 août 2025 : Finley a exercé 4 882 unités fantômes (Code M), acquérant le même nombre d’unités ordinaires WLKP sans coût en espèces. La détention directe d’unités ordinaires est passée à 31 930 unités contre environ 27 048, soit une augmentation d’environ 18 %.

Aucun achat ou vente sur le marché ouvert n’a été signalé, et les avoirs dérivés après les transactions déclarées s’élèvent aux 5 005 unités fantômes nouvellement attribuées. Le dépôt signale un alignement continu en actions par un membre du conseil, sans impliquer de transactions en espèces ni de modifications du flottant public.

Direktor G. Steven Finley reichte ein Formular 4 für Westlake Chemical Partners LP (WLKP) ein, das zwei Transaktionen am 6. und 7. August 2025 abdeckt.

  • Gewährung am 6. August 2025: Finley erhielt 5.005 Phantom-Einheiten (wirtschaftliches Äquivalent zu Stammaktien). Diese werden am 6. August 2026 fällig/ausübbar und verfallen am 6. September 2026; der gemeldete Anschaffungspreis beträgt 0 $.
  • Ausübung am 7. August 2025: Finley übte 4.882 Phantom-Einheiten (Code M) aus und erwarb die gleiche Anzahl von WLKP-Stammaktien ohne Barausgabe. Die direkten Stammaktienbestände stiegen von etwa 27.048 auf 31.930 Einheiten, eine Steigerung von ca. 18 %.

Es wurden keine Käufe oder Verkäufe am offenen Markt gemeldet, und die Derivatbestände nach den gemeldeten Transaktionen belaufen sich auf die neu gewährten 5.005 Phantom-Einheiten. Die Meldung signalisiert eine fortgesetzte Aktienausrichtung eines Vorstandsmitglieds, beinhaltet jedoch keine Bartransaktionen oder Änderungen des Streubesitzes.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FINLEY G STEPHEN

(Last) (First) (Middle)
2801 POST OAK BLVD., STE. 600

(Street)
HOUSTON TX 77056

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Westlake Chemical Partners LP [ WLKP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Units 08/07/2025 M 4,882 A (1) 31,930 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Units (1) 08/06/2025 A 5,005 08/06/2026 09/06/2026 Common Units 5,005 $0 0 D
Phantom Units (1) 08/07/2025 M 4,882 08/07/2025 09/07/2025 Common Units 4,882 $0 0 D
Explanation of Responses:
1. Each Phantom Unit is the economic equivalent of one Common Unit of the Issuer.
Remarks:
Mr. Finley is a Director of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP.
G. Steven Finley by J Feng POA 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions were reported for WLKP on 8 Aug 2025?

Director G. Steven Finley was granted 5,005 phantom units and converted 4,882 phantom units into common units.

How many WLKP common units does the director own after the filing?

Finley now holds 31,930 common units directly.

Was any cash paid for the units acquired?

No. Both the grant and the conversion carried a $0 exercise price.

When do the newly granted phantom units vest?

The 5,005 phantom units become exercisable on 08/06/2026 and expire on 09/06/2026.

Does the filing materially affect WLKP’s share count or earnings?

The amounts are immaterial to float and earnings; no immediate financial impact is expected.
Westlake Chem Partners Lp

NYSE:WLKP

WLKP Rankings

WLKP Latest News

WLKP Latest SEC Filings

WLKP Stock Data

772.43M
19.27M
44.8%
33.6%
0.28%
Chemicals
Industrial Organic Chemicals
United States
HOUSTON